Publication | Open Access
Real World Experience of Nivolumab in Non-Small Cell Lung Cancer in Korea
15
Citations
16
References
2020
Year
This real-world analysis supports the use of nivolumab for pretreated NSCLC patients, including those with an older age.
| Year | Citations | |
|---|---|---|
Page 1
Page 1